Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
22 February 2024
- European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada Insight, Corporate 08 December 2025 European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada
- Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US Press Release, Product 08 December 2025 Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
- Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables Story, Leadership 24 November 2025 Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables
- Hikma celebrates 20 years on the London Stock Exchange Story, Corporate 20 November 2025 Hikma celebrates 20 years on the London Stock Exchange
Related content